ArticleFrontiers in medicine2026
Latin American expert opinion paper on the diagnosis and treatment of pulmonary hypertension associated with interstitial lung disease.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary hypertension associated with interstitial lung disease (PH-ILD) represents a major clinical challenge due to its impact on prognosis and the complexity of diagnosis and management. The objective of this work was to develop practical, region-specific guidelines primarily aimed at supporting healthcare professionals in Latin America. A multidisciplinary working group of Latin American experts in PH-ILD developed an expert opinion paper, from which a diagnostic and therapeutic algorithm was derived. The resulting algorithm provides a stepwise approach to identifying suspected PH in patients with interstitial lung disease, confirming the diagnosis, and guiding management and treatment. Clinical, functional, biological, and imaging findings, including transthoracic Doppler echocardiography, are integrated to estimate the probability of PH, with tricuspid regurgitation velocity used to stratify risk. Right heart catheterization is proposed to confirm the diagnosis and to inform treatment decisions according to current recommendations. This algorithm offers a structured and practical tool that may facilitate earlier diagnosis and support appropriate management of patients with PH-ILD in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.